Atrandi Biosciences is a Lithuanian biotech startup that aims to commercialize droplet microfluidics technology.
Atrandi Biosciences has raised $25.0M in total funding. The most recent round was Series A. The last funding was announced in February 2025.
Atrandi Biosciences's investors include Vsquared Ventures, Lux Capital, Microsoft, Practica Capital, GRIDS Capital.
Atrandi Biosciences is headquartered in Vilnius, Lithuania.
Atrandi Biosciences is a Lithuanian biotech startup that aims to commercialize droplet microfluidics technology.
Atrandi Biosciences is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Atrandi Biosciences — Funding & Investors." VCBacked, February 18, 2025, https://www.vcbacked.co/company/atrandi-biosciences. Accessed July 19, 2026.
VCBacked. (2025). Atrandi Biosciences — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/atrandi-biosciences
{{cite web |title=Atrandi Biosciences — Funding & Investors |url=https://www.vcbacked.co/company/atrandi-biosciences |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated